Inside the Clinic: A Team-Based Approach to Management of GVHD

A multidisciplinary team from Dana-Farber Cancer Institute discusses their approach to the care of patients with graft versus host disease.

EP. 1: Clinical Scenario: A 38-Year-Old Man with Ph+ ALL

July 31st 2023

Bonnie Dirr, APRN, introduces a clinical scenario of a patient who received an allogeneic stem cell transplant from a sibling donor to begin the panel’s discussion of graft versus host disease.

EP. 2: GVHD Incidence and Pathophysiology

July 31st 2023

Mahasweta Gooptu, MD, reviews statistics on graft versus host disease and explains the desired graft versus leukemia effect.

EP. 3: Conditioning Regimens for Stem Cell Transplantation

August 7th 2023

Eno-Abasi Inyang, PharmD, BCPS, BCOP provides an overview of the various conditioning regimens employed for allogeneic stem cell transplantation.

EP. 4: Risk Factors for Acute and Chronic GVHD

August 7th 2023

Dr. Gooptu explains the risk factors associated with both acute and chronic GVHD.

EP. 5: The GVHD Prophylaxis Landscape

August 14th 2023

GVHD prophylaxis techniques are analyzed by the panelists.

EP. 6: Acute GVHD Presentation and Diagnosis

August 14th 2023

Acute GVHD presentation and diagnosis is assessed for the clinical scenario previously discussed.

EP. 7: Assessment and Grading of Acute GVHD

August 21st 2023

Dr Gooptu shares guidance on the assessment and grading of acute GVHD.

EP. 8: Frontline Steroid Treatment for Acute GVHD

August 21st 2023

Drs Gootpu and Inyang explain use of corticosteroids as frontline treatment for acute GHVD.

EP. 9: Education and Resources for Patients with GVHD

August 28th 2023

The panel highlights the importance of a multidisciplinary approach and best practices in education for patients with GVHD.

EP. 10: Clinical Scenario: Chronic Graft Versus Host Disease

August 28th 2023

Signs and symptoms of chronic GVHD are explained through the lens of the clinical scenario.